Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.
about
Conformational changes of blood ACE in chronic uremia.PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme.ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients.Identifying Common Genetic Risk Factors of Diabetic Neuropathies.The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes.Angiotensin I-converting enzyme gene (I/D) polymorphism in patients with migraine.Pharmacogenomics in heart failure: individualizing therapy based on genotype.ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes.The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis.
P2860
Q34482175-7E9C0D7C-94B3-4DAB-B9A5-4A4BC27D14E5Q34994915-96339739-3B6A-43F1-B3A4-4AA8653E30E8Q36666911-795054EF-27E6-441A-9495-F9ECBDB6BFAEQ37646842-7617A82A-F33C-4177-BC73-4882CE6B633AQ37697564-20CD844A-B0C4-4DAB-9FF7-99675F595744Q38527798-C7E0A466-9D60-4322-A870-D9EB273227F0Q43011211-4D2BA260-1D88-4BC4-A6F6-AE7235FCA860Q43665387-19115F5E-0870-49E3-9E15-B187CC517FF9Q44681090-FD495F26-2621-412B-8BF5-2843EF6DDB7DQ50956599-55E70536-D19E-42B3-8D7C-79FE2704665EQ54478891-16DDA28D-DD08-4733-AEF6-B9D5F512710DQ54523446-FDB9D1F3-7BC6-4E1B-93D1-498714B49ACF
P2860
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Does the Angiotensin-convertin ...... therapy?--A systematic review
@nl
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@ast
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@en
type
label
Does the Angiotensin-convertin ...... therapy?--A systematic review
@nl
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@ast
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@en
prefLabel
Does the Angiotensin-convertin ...... therapy?--A systematic review
@nl
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@ast
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@en
P2093
P2860
P356
P1476
Does the Angiotensin-convertin ...... therapy?--A systematic review.
@en
P2093
Annalisa Perna
Johann Steurer
Lucas M Bachmann
Madlaina Scharplatz
Milo A Puhan
P2860
P2888
P356
10.1186/1468-6708-6-16
P407
P577
2005-10-24T00:00:00Z
P5875
P6179
1035521195